US EditionWeight Loss Jabs Could Be Starting to Affect Shopping Habits in UK Supermarkets
- GPs across England began prescribing Mounjaro to severely obese patients under a new NHS rollout expanding access beyond specialised clinics.
- This initiative aims to reach about 220,000 people over three years, targeting those with the greatest need amid rising obesity rates.
- The surge in weight loss drug prescriptions, nearly doubling from 1.4 million to 2.7 million last year, coincides with a 0.4% drop in grocery sales.
- Fraser McKevitt of Kantar noted four in 100 households now include a GLP-1 weight loss drug user, and said these drugs could influence shopping behaviours.
- The growing drug use and changing health priorities suggest supermarkets may face shifting consumer habits despite steady trip numbers and rising prices.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
4
Center
3
Right
2
Slim pickings: grocery sales down as Brits turn to weight-loss jabs
The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away from more than just unhealthy food. Four per cent of households in the UK now have at least one member using GLP-1, the active ingredient in weight-loss drugs. The share of UK households with at least one GLP-1 user has almost doubled in size from 2.3 per cent to 4.1 per cent in the last year, according to retail experts …
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources11
Leaning Left4Leaning Right2Center3Last UpdatedBias Distribution44% Left
Bias Distribution
- 44% of the sources lean Left
44% Left
L 44%
C 33%
R 22%
Factuality
To view factuality data please Upgrade to Premium
